REFERENCES
- Foster T S, Miller J D, Marton J P, Caloyeras B A, Russell M W, Menzin J. Assessment of the economic burder of COPD in the U.S.: a review and synthesis of the literature. COPD 2006; 3(4)211–218
- Nurmagambetov T, Atherly A, Williams S, Holguin F, Mannino D M, Redd S C. What is the cost to employers of direct medical care for chronic obstructive pulmonary disease?. COPD 2006; 3(4)203–209
- Gross C P, Anderson G F, Powe N R. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999; 340: 1881–1887, [INFOTRIEVE], [CROSSREF], [CSA]
- National Heart, Lung, and Blood Institute. Morbidity and Mortality: 2004 Chart Book on Cardiovascular, Lung, and Blood Diseases. National Heart, Lung, and Blood Institute. May, 2004, http://www.nhlbi.nih.gov/resources/docs/cht-book.htm
- Mapel D W, Hurley J S, Frost F J, Peterson H V, Picchi M A, Coultas D B. Health care utilization in chronic obstructive pulmonary disease: a case-controlled study in a health maintenance organization. Arch Intern Med 2000; 160: 2653–2658, [INFOTRIEVE], [CROSSREF], [CSA]
- Halpin D MG. Health economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 227–233, [INFOTRIEVE], [CROSSREF], [CSA]